COMMUNIQUÉS West-GlobeNewswire

Cosmos Health Purchases $600,000 of Bitcoin, Expands Digital Asset Holdings to $3,100,000
11/03/2026
CHICAGO, March 11, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced the purchase of $600,000 of [...]
Solid Biosciences Provides Interim Positive Clinical Update on Phase 1/2 INSPIRE DUCHENNE Trial
11/03/2026
- 40 participants have been dosed with SGT-003 in the INSPIRE DUCHENNE trial to date - - Robust microdystrophin expression with consistent mechanistic evidence of dystrophin associated protein complex (DAPC) restoration [...]
GUERBET : Evolution du Conseil d’Administration de Guerbet.
11/03/2026
Evolution du Conseil d’Administration de Guerbet Villepinte, le 11 mars 2026 : Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l’imagerie médicale, annonce la nomination ce [...]
GUERBET : Change in Guerbet’s Board of Directors.
11/03/2026
Change in Guerbet’s Board of Directors Villepinte, March 11th, 2026: Guerbet (FR0000032526 GBT), a global leader in contrast agents and solutions for medical imaging, today announced, at its Board of Directors’ meeting [...]
GUERBET : Résultats annuels 2025.
11/03/2026
Résultats annuels 2025 Chiffre d’affaires : 786,4 M€, soit un repli de 3,5% à TCC 1 et périmètre comparable 2 , dû essentiellement à la baisse de l’activité en France Rentabilité : la marge d’EBITDA retraité 3 ressort à [...]
GUERBET : 2025 full-year results.
11/03/2026
2025 full-year results Revenue : €786.4 million, down 3.5% at CER 1 and like-for-like 2 , mainly due to the fall in activity in France Profitability : restated EBITDA margin 3 of 12.0% (at the high end of the adjusted [...]
Io Therapeutics, Inc. announces publication of studies on the company’s RXR agonist compound IRX4204 for breast cancer prevention
11/03/2026
SPRING, Texas, March 11, 2026 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc. in Spring, Texas, announces collaborative publication of data from preclinical studies with scientists at The University of Texas MD Anderson [...]
Philips expands digital pathology portfolio with cloud-enabled Philips IntelliSite Pathology Solution on HealthSuite
11/03/2026
March 11, 2026 Fully cloud ‑ enabled solution designed to help healthcare organizations scale digital pathology adoption and workflows Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader [...]
Toro Neurovascular Announces FDA 510(k) Clearance for Toro 88 Superbore Catheter
11/03/2026
First clinical cases successfully completed; U.S. launch to be led by Kaneka’s Neurovascular division IRVINE, Calif., March 11, 2026 (GLOBE NEWSWIRE) -- Toro Neurovascular today announced that the U.S. Food and Drug [...]
Nelipak Announces Opening of Asia-Pacific Technical Development Center
11/03/2026
New Singapore facility integrates flexible and rigid sterile barrier packaging systems development under one roof to simplify and accelerate package design and speed to market (L-R) Roger Prevot, Chairman, Nelipak, [...]
PolTREG poursuit la procédure d’enregistrement au niveau européen de sa thérapie à base de TREG destinée au traitement du diabète de type 1
11/03/2026
L’Agence européenne des médicaments (EMA) a officiellement autorisé PolTREG à déposer une demande d’autorisation de mise sur le marché dans l’Union européenne pour la préparation cellulaire PolTREG-T1D. GDAŃSK, Pologne [...]
Inc. Names Commure’s Deepika Bodapati to Its 2026 Female Founders 500 List
11/03/2026
Inc.’s annual Female Founders list celebrates the nation’s most innovative women entrepreneurs, who collectively generated approximately $12.3 billion in 2025 MOUNTAIN VIEW, Calif., March 11, 2026 (GLOBE NEWSWIRE) -- [...]
Albanian-Finnish Startup Bliss Raises $270K to Build Culturally Intelligent AI for Therapy
11/03/2026
Helsinki, Finland, March 11, 2026 (GLOBE NEWSWIRE) -- Bliss , a Finland-headquartered mental health startup originally founded in Albania, has raised $270,000 in angel funding led by Keiretsu Forum, Finest Love VC and [...]
MAPS, in Partnership with the Shulgin Foundation, Launches Music Is the Bridge Video Series; First Episode Features Reggie Watts and Hamilton Morris
11/03/2026
Premiere episode features Reggie Watts and Hamilton Morris in conversation at the historic Shulgin laboratory Filmed on-site, the episode documents the lab where Sasha Shulgin resynthesized MDMA and developed hundreds [...]
Financière de Tubize - Investor call - 23/03/2026 - 17:00 CET
11/03/2026
Dear Investors, We will host an online investor call to present our annual results on March 23, 2026 at 17:00 CET. If you would like to join us, please register by clicking on or copying following link https://forms. [...]
Financière de Tubize - Investor call - 23/03/2026 - 17:00 CET
11/03/2026
Chers investisseurs, Nous organisons une réunion en ligne afin de présenter nos résultats annuels le 23 mars 2026 à 17h00 CET. Si vous souhaitez nous rejoindre, veuillez vous inscrire en cliquant sur le lien suivant : [...]
Corporate Update: Psyence BioMed Advances Vertically Integrated Pharmaceutical Platform Following PsyLabs Export Milestone
11/03/2026
“The strongest companies are built on the right foundations long before their moment arrives,” says CEO Jody Aufrichtig NEW YORK, March 11, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed [...]
24/7 Market News: Kraig Labs the Bootstrapped Unicorn in the Making
11/03/2026
DENVER, March 11, 2026 (GLOBE NEWSWIRE) -- 247marketnews.com -- In technology and biotechnology, “unicorn” status is typically reserved for private companies valued at $1 billion or more; often backed by major venture [...]
Clearmind Medicine Advances Recruitment for CMND-100 Trial's Third Cohort at Yale, Johns Hopkins and Tel Aviv Sites Following Recent Positive Topline Results
11/03/2026
Vancouver, Canada, March 11, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non- [...]

Pages